Kebo Zhong
About
In The Last Decade
Kebo Zhong
16 papers receiving 246 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 151
- Cancer Research 51
- Oncology 48
- Immunology 41
- Surgery 37
Countries citing papers authored by Kebo Zhong
This map shows the geographic impact of Kebo Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kebo Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kebo Zhong more than expected).
Fields of papers citing papers by Kebo Zhong
This network shows the impact of papers produced by Kebo Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kebo Zhong. The network helps show where Kebo Zhong may publish in the future.
Co-authorship network of co-authors of Kebo Zhong
This figure shows the co-authorship network connecting the top 25 collaborators of Kebo Zhong. A scholar is included among the top collaborators of Kebo Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kebo Zhong. Kebo Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 8 | |
| 3 | 0 | |
| 4 | 19 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 95 | |
| 9 | 33 | |
| 10 | [Differential expressions of microRNAs and their predicted targets in liver transplant recipients with long-term stable survival]. | 1 |
| 11 | 52 | |
| 12 | 1 | |
| 13 | [Relationship between the expressions of indoleamine 2, 3-dioxygenase in hepatocellular carcinoma and clinicopathological parameters]. | 4 |
| 14 | [Expression of Nusap1 in the surgical margins of hepatocellular carcinoma and its association with early recurrence]. | 7 |
| 15 | [Expression of SATB1 in hepatocellular carcinoma cell lines with different invasive capacities]. | 5 |
| 16 | [Safety and efficacy of Sorafenib in treatment of tumor recurrence in liver transplantation recipients]. | 3 |
| 17 | [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance]. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.